Nanjing Vazyme Biotech Co., Ltd.
SSE:688105.SS
22.71 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -19.623 | -70.956 | 593.507 | 678.29 | 821.725 | 25.795 | 1.039 | 3.645 |
| Depreciation & Amortization
| 152.51 | 157.377 | 122.099 | 55.277 | 13.727 | 7.21 | 4.39 | 2.617 |
| Deferred Income Tax
| 0 | -49.07 | -35.047 | -15.006 | 18.836 | -12.507 | -6.679 | 0 |
| Stock Based Compensation
| 0 | 19.074 | 7.375 | 7.469 | 10.617 | 5.298 | 6.276 | 0 |
| Change In Working Capital
| -240.289 | -149.903 | -657.183 | -183.37 | -104.498 | -34.551 | -22.234 | -19.397 |
| Accounts Receivables
| -188.248 | 534.672 | -682.891 | -133.201 | -164.364 | -32.82 | -22.239 | 0 |
| Inventory
| -39.04 | -124.372 | -403.821 | -148.944 | -128.205 | -26.517 | -12.979 | -9.72 |
| Accounts Payables
| 0 | -511.134 | 464.577 | 113.781 | 169.234 | 37.292 | 19.662 | 0 |
| Other Working Capital
| -13.001 | -49.07 | -35.047 | -15.006 | 18.836 | -12.507 | -9.256 | -9.677 |
| Other Non Cash Items
| 97.72 | 291.883 | 704.414 | 74.14 | 43.145 | 23.957 | 12.806 | 9.276 |
| Operating Cash Flow
| -9.682 | 198.405 | 735.166 | 616.801 | 803.553 | 15.202 | -3.999 | -3.86 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -74.896 | -232.901 | -962.86 | -261.96 | -152.543 | -19.882 | -32.133 | -18.821 |
| Acquisitions Net
| 0 | 0 | -117.927 | 2.726 | 152.716 | 19.918 | -0 | 18.821 |
| Purchases Of Investments
| -6,698.732 | -6,005.783 | -9,163.214 | -6,502.284 | -3,992.97 | -209.95 | -102.9 | -207.12 |
| Sales Maturities Of Investments
| 7,146.362 | 5,279.133 | 9,275.977 | 5,333.43 | 3,212.308 | 241.989 | 78.753 | 247.821 |
| Other Investing Activites
| 2.474 | 58.9 | 15.588 | 0 | -152.543 | -19.882 | 0.054 | -18.821 |
| Investing Cash Flow
| 375.208 | -900.651 | -952.437 | -1,428.087 | -933.031 | 12.194 | -56.226 | 21.88 |
| Financing Activities: | ||||||||
| Debt Repayment
| -618.821 | 822.214 | 215.59 | -39.556 | -34.49 | 0 | 0 | 0.72 |
| Common Stock Issued
| 0 | 0 | 0 | 2,113.773 | 297.144 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -20.01 | 0 | -2,113.773 | -297.144 | 0 | 0 | 0 |
| Dividends Paid
| -80.363 | -500.013 | -120.003 | -4.445 | -1.452 | -1.253 | -0.868 | -0.291 |
| Other Financing Activities
| -87.086 | -72.4 | -16.536 | 2,113.773 | 297.144 | 6.327 | 33.557 | 0 |
| Financing Cash Flow
| -786.271 | 249.801 | 79.051 | 2,069.771 | 261.202 | 5.074 | 32.689 | 0.429 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -4.237 | 1.463 | 5.041 | -2.318 | -3.895 | 0.019 | 0.015 | -0.028 |
| Net Change In Cash
| -424.981 | -496.399 | -133.179 | 1,256.168 | 127.829 | 32.489 | -27.521 | 18.421 |
| Cash At End Of Period
| 423.21 | 848.191 | 1,344.591 | 1,477.77 | 221.602 | 93.773 | 61.284 | 88.805 |